CIHD Rapid Core Access (CRCA) Applications are accepted on a rolling basis.

Award Overview

CIHD Rapid Core Access Awards provide up to $10,000 in core-service support for work conducted in one of the CIHD cores. Rapid Core Access awards provide immediate funding and access to specialized CIHD services and expertise for pilot studies, feasibility testing, and acquisition of new technical skills or preliminary data.

This mechanism is especially well suited for trainees and early-stage investigators as well as established investigators seeking to establish new approaches, generate data for subsequent extramural applications, or strengthen their competitiveness for fellowships and career-development awards.

Projects must align with the NIDDK Hematology mission( https://www.niddk.nih.gov/research-funding/research-programs#hematologic-diseases) in non-malignant hematology. The application should include a brief statement describing this relevance.

Eligible CIHD Cores

  • Iron and Heme Core
  • Metabolomics and Lipidomics Core
  • Protein Metabolite Discovery Core

Applications are reviewed as needed on an ad-hoc basis by CIHD directors and Core directors. This streamlined process is intended to support timely, equitable access to CIHD resources.

Application Requirements

New applications should be submitted as a single PDF using 11-point Arial font and 0.5-inch margins. Applications must include:

  • Page 1: Project title, applicant/PI (name and contact information), and abstract (200 words). Funded-project abstracts will be made public.
  • Page 2: Project description, significance, figures, and literature cited. Include a statement describing relevance to NIDDK hematology mission (https://www.niddk.nih.gov/research-funding/research-programs#hematologic-diseases)
  • Page 3: Proposed CIHD core use, budget, and budget justification. Applications from trainees or junior investigators must be signed by the supervising PI.
  • NIH-style biosketch: Applicant only.

Core Approval and Project Period

Applicants may request support from one or more CIHD cores. Before submission, applicants must obtain written approval from the relevant Core Directors confirming the proposed services, estimated costs, and project feasibility.

CIHD Rapid Core Access projects do not require institutional approval from the applicant’s grants and contracts office unless required by the applicant’s institution. Project periods may extend for up to 12 months or the end of the grant budget period. Awardees must submit a progress report within 120 days of the project end date.

Please refer to Core descriptions and contact information on our home page.

Please address any questions or concerns to anna.beaudin@hsc.utah.edu.

Submit Application Here

Email
Drag & Drop Files, Choose Files to Upload

CIHD Pilot and Feasibility Program Grant Awards

2025 – 2026

Kevin Hicks, PhD, University of Utah: Citrate as a metabolic regulator of transferrin-mediated iron thrombosis

Aaron Petrey, PhD, University of Utah: Heparin sulfate remodeling as a novel regulator of hematopoiesis

2024 – 2025

Shannon Buckley, PhD, University of Utah: Role of ubiquitin E3 ligase FBXL6 in hematopoietic development and myelodysplastic syndrome

Dengke K. Ma, PhD, UCSF School of Medicine: Investigating the Antioxidant Functions of TMEM161B: Heme Binding and Mechanistic Roles in Human Cells

2023 – 2024

Ella Nemeth, PhD, University of California Los Angeles: Iron Deficiency enhances endothelial damage in sepsis: the role of heme

Jan Christian, PhD, University of Utah and Jodie Babitt, M.D. Mass General Hospital, Harvard: Analysis of a mouse model of a BMP6 mutation associated with iron overload in humans

2022 – 2023

Anna Beaudin, PhD, University of Utah: Delaying age and obesity-mediated hematopoietic dysfunction with time-restricted feeding.

Dean Tantin, PhD, University of Utah: Test the hypothesis that Oct1 can be used to improve blood cell development.

2021 – 2022

Paul Sigala, PhD, University of Utah: Unraveling the Mechanism and Biological Significance of Hemozoin Motion in Malaria Parasites.

Diane Ward, PhD, University of Utah: The role of macrophage Cyb561a3/Lcytb in lysosomal iron recycling for erythropoiesis.

Iqbal Hamza, PhD University of Maryland, College Park: Interactions of HRG1 heme transporter in reticuloendothelial macrophages.

2020 – 2021

Ryan O’Connell, PhD, University of Utah: The role of Rab27a/b during mitochondria release from maturing erythroblasts

Paul Sigala, PhD, University of Utah: Mechanism of Iron Acquisition by Malaria Parasites

Diane Ward, PhD, University of Utah: The role of the reductases Lcytb and Steap3 in lysosomal iron recycling in macrophages

Adam Hughes, PhD, University of Utah: Elucidating the role of the LON protease in the regulation of cellular iron metabolism.

Robert Christensen, MD, University of Utah: Neonatal iron deficiency; defining pathogenic mechanisms & improving detection.

Tomas Ganz, MD, UCLA: Metabolic Effects of Pathologically Increased Erythroferrone in Anemias with Ineffective Erythropoiesis.

Amy Medlock, PhD, University of Georgia: Creation of Transgenic Zebrafish with Hepatic and Erythroid Expressed Heme Sensors

Yvette Yien, PhD, University of Pittsburg: Regulation of erythroid heme synthesis and vertebrate development by the mitochondrial unfoldase, CLPX.

Francesca Vinchi, PhD, New York Blood Center: Characterization of macrophage immune-metabolic skewing induced by heme, iron and erythrophagocytosis.

Timothy M Barr, MS MD, University of Utah: Iron deficiency in preterm neonates: prevalence, surveillance, contributing factors.

Makiko Yasuda, MD PhD, Icahn School of Medicine at Mt Sinai: Investigations of hepatic heme homeostatic mechanisms using ALAS-deficient mice.

2019 – 2020

Ryan O’Connell, PhD, University of Utah: The role of Rab27a/b during mitochondria release from maturing erythroblasts

Paul Sigala, PhD, University of Utah: Mechanism of Iron Acquisition by Malaria Parasites 3.

Diane Ward, PhD, University of Utah: The role of the reductases Lcytb and Steap3 in lysosomal iron recycling in macrophages

2018 – 2019

Dean Tantin, PhD, Tracey Lamb, PhD: Does Oct1 loss-of-function in bone marrow progenitor cells exacerbate the severity of malarial anemia?

Oleh Khalimonchuk, PhD, Amit Reddi, PhD: Mitochondrial Behavior and Heme Transport in Erythropoiesis

Elizabeth Leibold, PhD, University of Utah: Cell-Cycle Regulation of IRP2 Phosphorylation during Hematopoiesis

Amy Medlock, PhD, Amit Reddi, PhD: Creation of Transgenic Zebrafish with Erythroid Expressed Heme Sensors

Ryan O’Connell, PhD University of Utah: Determine the role of Rab27a/b during mitochondria release from maturing erythroblasts

Joe Prchal, University of Utah: Search for Novel Parameters of Augmentation of Erythropoiesis. Deciphering Molecular Differences of VHL Mutated Congenital Polycythemia versus Tumor-Predisposition

Paul Sigala, PhD, University of Utah: Structure and Function of a Divergent Eukaryotic Cytochrome c

Diane Ward, PhD, University of Utah: The role of Abcb10 in red cell hemoglobinization

2017 – 2018

Matthew Barber, PhD, University of Oregon: Host-pathogen conflicts shaping bloodstream hemeprotein evolution

Adam Hughes, PhD, University of Utah: The role of lysosomes in maintenance of cellular iron metabolism

Elizabeth Leibold, PhD, University of Utah: Cell-cycle regulation of IRP2 phosphorylation during hematopoiesis

Paul Sigala, PhD, University of Utah: Role of Acyl Carrier Protein in Iron/Sulfur Cluster Biogenesis by Malaria Parasites

Diane Ward, PhD, University of Utah: The role of Abcb10 in red cell hemoglobinization

2016 – 2017

Dr. Paul Sigala PhD, University of Utah: Department of Biochemistry, University of Utah: the role of the acyl-carrier proteins present in the mitochondria and apicoplast of Plasmodium in iron-sulfur cluster biogenesis in the two organelles and the role of each pathway in the physiology of Plasmodium parasites.

Dr. Amy Medlock PhD, University of Georgia: the role of two novel proteins PGRMC1 and PGRMC2 in modulating heme synthesis in mammalian cells.

Dr. Matt Barber, PhD, University of Oregon: the evolutionary battle between pathogens and primate hosts for access to iron and heme.